Space-based cancer drug crystal growth shows promise, faces cost hurdles

Pharmaceutical companies are testing production of cancer drug crystals in microgravity aboard a space capsule at ~480 km altitude, aiming for easier-to-administer treatments. The approach is exploratory; high costs and reproducibility issues remain, and no clinical results are reported.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works